Archive - FemmeHealth Ventures Alliance

Gates’ $2.5 Billion Women’s Health Bet: Will Private Capital Be Ready to Catch It?

History shows that catalytic grants spark breakthroughs but lasting impact depends on private capital stepping in at the right moment.

Aug 17 •

The Silent Punishment of Midlife Women at Work

When Ambition Collides with Biology

Aug 14 •

Is It Brain Fog or Just Dopamine?

It Started with a Glitch: Tracking the Midlife Chemistry Shift No One Talks About

Aug 10 •

A Drop of Blood That Could Save Millions: The Future of Preeclampsia Diagnosis

Why we’re still using 100-year-old tools to detect one of the deadliest pregnancy complications and how one startup plans to change that.

Aug 7 •

26:05

Why Innovation in Women’s Health Still Lags And What Needs to Change

Despite growing demand, women’s health remains chronically underfunded. This essay unpacks the incentive structures stalling progress in menopause care…

Aug 3 •

July 2025

The Midlife Vanishing: Why Women Are Quietly Leaving and No One’s Asking Why

From menopause to market forces, this is the real reason high-performing women are vanishing and no one is fixing it.

Jul 27 •

Blind Spot Capital is Here!

The podcast where health innovation meets investment insight because the future of women’s health won’t fund itself.

Jul 24 •

1:13

Why Longevity Tech Is Failing Women Over 40

We are coding the future of health around male defaults. Women over 40 are being left behind.

Jul 20 •

Alliance Spotlight — Dr. Maria Fay

This month we welcome Dr.

Jul 17 •

Longevity Misses the Mark: Why Menopause Is the Blind Spot in Aging Science

Women live longer but age worse. Why capital markets and medicine still ignore the biology behind midlife risk.

Jul 13 •

Why Erectile Dysfunction Gets Funded and Women’s Health Gets Dismissed

Capital follows what it values. When investors call women’s health “CSR,” they reveal a billion-dollar blind spot.

Jul 10 •

Even Venus Wasn’t Believed: The Hidden Cost of Delayed Diagnosis in Women’s Health

Why fibroids, funding, and disbelief go hand-in-hand and what investors are still missing.

Jul 6 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts